Search results
Results from the WOW.Com Content Network
The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
In the US, UK and the European Union, the most common type of artificial heart valve is the bioprosthetic valve. Mechanical valves are more commonly used in Asia and Latin America. [citation needed] Companies that manufacture heart valves include Edwards Lifesciences, [5] Medtronic, [6] Abbott (St. Jude Medical), [7] CryoLife, [8] and LifeNet ...
The Ireland-based company developed a number of implant systems and devices designed to enable transapical (through the apex of the heart) surgical access. [ 60 ] [ 61 ] In July 2015, it was announced that Thoratec would be acquired by St. Jude Medical , a global medical-device company headquartered in Saint Paul, Minnesota .
St. Jude Medical Announces European Approval of the Portico Transcatheter Aortic Heart Valve ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company ...
On Monday, St. Jude announced that it has acquired Switzerland's Endosense SA, a pioneer in measuring contact force in catheter ablation, for a purchase price of $170 million St. Jude Medical Buys ...
St Jude Medical's Portico Transcatheter aortic valve received European CE mark approval in December 2013. The valve is repositionable before release to ensure accurate placement helping to improve patient outcomes. [12] Edwards' Sapien aortic valve is made from bovine pericardial tissue and is implanted via a catheter-based delivery system. It ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company, today announced first enrollment of its MultiPoint ™ Pacing clinical study to build upon ...